Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for OncoVEX GM-CSF

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Other

    VICCMEL14103

    08/17/2015

    A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials

    Treatment

    VICCMEL1451

    01/26/2015

    A Phase 1b/3, Multicenter, Trial of Talimogene Laherparepvec in Combination With Pembrolizumab (MK-3475) for Treatment of Unresectable, Stage IIIB to IVM1c Melanoma (MASTERKEY-265)


    Print this page for your doctor